Diferencia entre revisiones de «Loperamide toxicity»
Sin resumen de edición |
|||
| Línea 5: | Línea 5: | ||
*May have features of conventional [[opioid toxicity]] | *May have features of conventional [[opioid toxicity]] | ||
===[[Loperamide]]-induced cardiac toxicity=== | ===[[Loperamide]]-induced cardiac toxicity<ref>Wu PE, et al. "Clinical Review: Loperamide Toxicity." Annals of EM. August 2017. 70(2):245-252</ref>=== | ||
*Often young | *Often young | ||
*May present in cardiac arrest or with recurrent [[syncope]] in conjunction with [[ECG]] agnormalities | *May present in cardiac arrest or with recurrent [[syncope]] in conjunction with [[ECG]] agnormalities | ||
Revisión del 07:17 14 ago 2017
Background
- Increasing reports of intentional overdose at very high doses either for euphoric effects or to attenuate symptoms of opioid withdrawal[1]
Clinical Features
- May have features of conventional opioid toxicity
Loperamide-induced cardiac toxicity[2]
- Often young
- May present in cardiac arrest or with recurrent syncope in conjunction with ECG agnormalities